Abstract
This study attempted to clarify the effects of therapeutic neovascularization by bone marrow cells for salvaging flaps after ischemia-reperfusion injury. Bone marrow mononuclear cell layer (endothelial progenitor cell-enriched fraction) was isolated from the mouse femur and tibia. Symmetrical double flaps were elevated in mice. Each flap topically received phosphate buffered saline (PBS) or bone marrow cells in PBS. Flaps were subjected to 6-hour ischemia and subsequent reperfusion. On the seventh postoperative day, the flap survival area was measured (n = 27). The mean survival area of bone marrow cells-transplanted flaps was 66.3 ± 18.0%, whereas control flaps showed a survival area of 49.7 ± 22.2%. The difference was highly significant (P = 0.000209). Histologic examination revealed the average vascular density of bone marrow cells-transplanted flaps had significantly increased. The present study proved bone marrow cells acted with significant efficacy in promoting the survival of ischemia-reperfusion-mediated damaged tissue.
| Original language | English |
|---|---|
| Pages (from-to) | 414-418 |
| Number of pages | 5 |
| Journal | Annals of Plastic Surgery |
| Volume | 52 |
| Issue number | 4 |
| DOIs | |
| Publication status | Published - 2004 Apr |
| Externally published | Yes |
ASJC Scopus subject areas
- Surgery
Cite this
Bone Marrow Cell Implantation Improves Flap Viability after Ischemia-Reperfusion Injury. / Ichioka, Shigeru; Kudo, Satoshi; Shibata, Masahiro; Ando, Joji; Sekiya, Naomi; Nakatsuka, Takashi.
In: Annals of Plastic Surgery, Vol. 52, No. 4, 04.2004, p. 414-418.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Bone Marrow Cell Implantation Improves Flap Viability after Ischemia-Reperfusion Injury
AU - Ichioka, Shigeru
AU - Kudo, Satoshi
AU - Shibata, Masahiro
AU - Ando, Joji
AU - Sekiya, Naomi
AU - Nakatsuka, Takashi
PY - 2004/4
Y1 - 2004/4
N2 - This study attempted to clarify the effects of therapeutic neovascularization by bone marrow cells for salvaging flaps after ischemia-reperfusion injury. Bone marrow mononuclear cell layer (endothelial progenitor cell-enriched fraction) was isolated from the mouse femur and tibia. Symmetrical double flaps were elevated in mice. Each flap topically received phosphate buffered saline (PBS) or bone marrow cells in PBS. Flaps were subjected to 6-hour ischemia and subsequent reperfusion. On the seventh postoperative day, the flap survival area was measured (n = 27). The mean survival area of bone marrow cells-transplanted flaps was 66.3 ± 18.0%, whereas control flaps showed a survival area of 49.7 ± 22.2%. The difference was highly significant (P = 0.000209). Histologic examination revealed the average vascular density of bone marrow cells-transplanted flaps had significantly increased. The present study proved bone marrow cells acted with significant efficacy in promoting the survival of ischemia-reperfusion-mediated damaged tissue.
AB - This study attempted to clarify the effects of therapeutic neovascularization by bone marrow cells for salvaging flaps after ischemia-reperfusion injury. Bone marrow mononuclear cell layer (endothelial progenitor cell-enriched fraction) was isolated from the mouse femur and tibia. Symmetrical double flaps were elevated in mice. Each flap topically received phosphate buffered saline (PBS) or bone marrow cells in PBS. Flaps were subjected to 6-hour ischemia and subsequent reperfusion. On the seventh postoperative day, the flap survival area was measured (n = 27). The mean survival area of bone marrow cells-transplanted flaps was 66.3 ± 18.0%, whereas control flaps showed a survival area of 49.7 ± 22.2%. The difference was highly significant (P = 0.000209). Histologic examination revealed the average vascular density of bone marrow cells-transplanted flaps had significantly increased. The present study proved bone marrow cells acted with significant efficacy in promoting the survival of ischemia-reperfusion-mediated damaged tissue.
UR - http://www.scopus.com/inward/record.url?scp=16544378771&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=16544378771&partnerID=8YFLogxK
U2 - 10.1097/01.sap.0000099709.95938.59
DO - 10.1097/01.sap.0000099709.95938.59
M3 - Article
C2 - 15084889
AN - SCOPUS:16544378771
VL - 52
SP - 414
EP - 418
JO - Annals of Plastic Surgery
JF - Annals of Plastic Surgery
SN - 0148-7043
IS - 4
ER -